Month: August 2021

SAN DIEGO: SAN DIEGO, Aug. 31, 2021 /PRNewswire/ — A new study by researchers at Hospital for Special Surgery (HSS) in New York City could help orthopedic surgeons better identify which patients will benefit most from surgery to correct debilitating age-related deterioration of their foot arches. The findings, published in… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Aug. 31, 2021 /PRNewswire/ — LifeNet Health, the world’s leading provider of allograft biologics, is showcasing its comprehensive portfolio of advanced biomaterials at the 2021 AAOS Annual Meeting (Booth #1527) Sept. 1-3. Its featured solutions include ViviGen® Cellular Bone Matrix, the first and only osteobiologic designed… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Aug. 31, 2021 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced preliminary results from its Phase 1 clinical trial of P-PSMA-101, the Company’s solid… Click here to view original post… […]

James Rolke Revelation Biosciences, a San Diego biotech working on antiviral nasal drops, will go public as part of a reverse merger with the Petra Acquisitions SPAC announced Tuesday. The deal is for $73 million and comes after Revelation closed a $4.4 million Series A-1… Click here to view original post… […]

TRUMBULL, Conn.: TRUMBULL, Conn., Aug. 31, 2021 /PRNewswire/ — SAM? (Sustained Acoustic Medicine), ZetrOZ’s clinically proven, noninvasive pain relief device, will be on display at the 2021 Academy of Orthopaedic Surgeons (AAOS) in San Diego, California, from Aug. 31-Sept. 3. As a rule, orthopaedic surgeons first consider non-surgical options, such… Click here to view original post… […]

LA JOLLA, Calif.: LA JOLLA, Calif., Aug. 31, 2021 /PRNewswire/ — Avidity Biosciences, Inc. (NASDAQ: RNA) a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the Avidity management team will be participating at the following conferences: 2021 Wells Fargo… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Aug. 31, 2021 /PRNewswire/ — HUYABIO International (HUYABIO™), the leader in accelerating global development of China’s pharmaceutical innovations, announced today the filing of an investigational new drug application (IND) with the FDA for HBI-2376 along with Genhouse who has filed an IND with the Chinese Center… Click here to view original post… […]

TAIPEI and SAN DIEGO: TAIPEI and SAN DIEGO, Aug. 31, 2021 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today announced that its oral new drug, Silmitasertib, had received a positive feedback from an Independent Data… Click here to view original post… […]

KEELE, England: KEELE, England, Aug. 31, 2021 /PRNewswire/ — Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce that research results comparing the efficacy of Biocomposites calcium matrix products STIMULAN® and… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Aug. 30, 2021 /PRNewswire/ — NEUVOGEN, an immunoncology company, is pleased to announce the appointment of Dr. Jack Bui to its Scientific Advisory Board ("SAB") effective August 30, 2021. "We are thrilled to welcome Dr. Jack Bui to NEUVOGEN’s Scientific Advisory Board," said Todd Binder, Chief… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Aug. 30, 2021 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New… Click here to view original post… […]

NEW YORK & SAN DIEGO–(BUSINESS WIRE)– #biotechnews–Revelation Biosciences to Become Publicly Traded through a Merger with Petra Acquisition, Inc. Click here to view original post… […]